Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
428 participants
INTERVENTIONAL
2016-07-05
2019-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This solutions give a new opportunity for diagnosis, treatment, education, and rehabilitation, and make it possible to monitor patients with a number of chronic diseases. It also reduces socioeconomic disparity with regard to access to care and gives equal chances to patients from urban and rural areas.
This a randomized trial of telemedicine versus usual care alone to reduce hospitalization and emergency hospital admissions for Nursing Home Residents .
After an initial assessment , each participant is monitored by teleconsultation on six occasions over 12 months. Patients with usual care have an initial and a 12 months assessments.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effectiveness and Organizational Conditions of Effectiveness of Telemedicine in Establishments Providing Care for the Dependent Elderly
NCT03486977
The Impact of Telemedicine to Support Palliative Care Resident in Nursing Home
NCT02821143
Assessment of Teleconsulting in Nursing Homes
NCT02157740
Gerontological Telemonitoring of Older Adults Living in Nursing Homes With COVID-19 Disease
NCT04337788
Study Of Telemedicine Consultation at Home For Older Adults
NCT01324687
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Telemedicine
Usual care and telemedicine consultations during12 months.
Telemedicine
Usual Care
Usual care alone
Usual care during12 months.
Usual Care
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Telemedicine
Usual Care
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Resident in nursing homes
* Resident with multiples chronic diseases with at least two comorbidities
* Having given free and informed consent in writing and signed by himself and / or his legal representative
Exclusion Criteria
* Resident with a life-threatening disease
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Limoges
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thierry DANTOINE, MD
Role: PRINCIPAL_INVESTIGATOR
CHU Limoges
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de Gériatrie
Limoges, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Gayot C, Laubarie-Mouret C, Zarca K, Mimouni M, Cardinaud N, Luce S, Tovena I, Durand-Zaleski I, Laroche ML, Preux PM, Tchalla A. Effectiveness and cost-effectiveness of a telemedicine programme for preventing unplanned hospitalisations of older adults living in nursing homes: the GERONTACCESS cluster randomized clinical trial. BMC Geriatr. 2022 Dec 22;22(1):991. doi: 10.1186/s12877-022-03575-6.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
I14036/GERONTACCESS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.